ArticleLight, science & applications2023
Optofluidic transport and assembly of nanoparticles using an all-dielectric quasi-BIC metasurface.
Article in Light, science & applications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Reconfigurable multibeam engineering of Marangoni convection for programmable optofluidic steering.Nature communications · 2026Article
- Quasi-BIC metasurfaces enable rapid, localized singlet-oxygen generation.Light, science & applications · 2026Article
- Rapid trapping and label-free optical characterization of single nanoscale extracellular vesicles and nanoparticles in solution.Light, science & applications · 2026Article
- Electrically Tunable Optofluidic Metasurface.ACS nano · 2026Article
- Tunable 3D optohydrodynamic torques from optical phase gradient-driven colloidal assemblies.Science advances · 2026Article
- Perfect anomalous refraction metasurfaces empowered half-space optical beam scanning.Nature communications · 2025Article
- Optical sorting: past, present and future.Light, science & applications · 2025Review
- Recent Advancements in Nanophotonics for Optofluidics.Advances in physics: X · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Manipulating fluids by light at the micro/nanoscale has been a long-sought-after goal for lab-on-a-chip applications. Plasmonic heating has been demonstrated to control microfluidic dynamics due to the enhanced and confined light absorption from the intrinsic losses of metals. Dielectrics, the counterpart of metals, has been used to avoid undesired thermal effects due to its negligible light absorption. Here, we report an innovative optofluidic system that leverages a quasi-BIC-driven all-dielectric metasurface to achieve subwavelength scale control of temperature and fluid motion. Our experiments show that suspended particles down to 200 nanometers can be rapidly aggregated to the center of the illuminated metasurface with a velocity of tens of micrometers per second, and up to millimeter-scale particle transport is demonstrated. The strong electromagnetic field enhancement of the quasi-BIC resonance increases the flow velocity up to three times compared with the off-resonant situation by tuning the wavelength within several nanometers range. We also experimentally investigate the dynamics of particle aggregation with respect to laser wavelength and power. A physical model is presented and simulated to elucidate the phenomena and surfactants are added to the nanoparticle colloid to validate the model. Our study demonstrates the application of the recently emerged all-dielectric thermonanophotonics in dealing with functional liquids and opens new frontiers in harnessing non-plasmonic nanophotonics to manipulate microfluidic dynamics. Moreover, the synergistic effects of optofluidics and high-Q all-dielectric nanostructures hold enormous potential in high-sensitivity biosensing applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.